TNDMTANDEM DIABETES CARE INC

Nasdaq tandemdiabetes.com


$ 42.71 $ -1.27 (-2.89 %)    

Monday, 16-Sep-2024 15:59:56 EDT
QQQ $ 473.14 $ -2.10 (-0.44 %)
DIA $ 417.33 $ 2.44 (0.59 %)
SPY $ 562.48 $ 0.83 (0.15 %)
TLT $ 101.29 $ 0.92 (0.92 %)
GLD $ 238.61 $ -0.02 (-0.01 %)
$ 42.7
$ 43.89
$ 42.67 x 100
-- x --
$ 42.67 - $ 44.43
$ 13.82 - $ 53.69
965,038
na
2.8B
$ 1.38
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-01-2024 06-30-2024 10-Q
2 05-02-2024 03-31-2024 10-Q
3 02-21-2024 12-31-2023 10-K
4 11-01-2023 09-30-2023 10-Q
5 08-03-2023 06-30-2023 10-Q
6 05-03-2023 03-31-2023 10-Q
7 02-22-2023 12-31-2022 10-K
8 11-02-2022 09-30-2022 10-Q
9 08-03-2022 06-30-2022 10-Q
10 05-04-2022 03-31-2022 10-Q
11 02-22-2022 12-31-2021 10-K
12 11-03-2021 09-30-2021 10-Q
13 08-04-2021 06-30-2021 10-Q
14 05-05-2021 03-31-2021 10-Q
15 02-24-2021 12-31-2020 10-K
16 11-05-2020 09-30-2020 10-Q
17 07-30-2020 06-30-2020 10-Q
18 04-30-2020 03-31-2020 10-Q
19 02-24-2020 12-31-2019 10-K
20 11-04-2019 09-30-2019 10-Q
21 08-01-2019 06-30-2019 10-Q
22 04-30-2019 03-31-2019 10-Q
23 02-26-2019 12-31-2018 10-K
24 11-01-2018 09-30-2018 10-Q
25 07-30-2018 06-30-2018 10-Q
26 04-26-2018 03-31-2018 10-Q
27 03-01-2018 12-31-2017 10-K
28 10-26-2017 09-30-2017 10-Q
29 07-27-2017 06-30-2017 10-Q
30 04-27-2017 03-31-2017 10-Q
31 03-08-2017 12-31-2016 10-K
32 11-01-2016 09-30-2016 10-Q
33 07-28-2016 06-30-2016 10-Q
34 04-28-2016 03-31-2016 10-Q
35 02-24-2016 12-31-2015 10-K
36 10-29-2015 09-30-2015 10-Q
37 07-30-2015 06-30-2015 10-Q
38 04-30-2015 03-31-2015 10-Q
39 02-24-2015 12-31-2014 10-K
40 11-06-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 morgan-stanley-initiates-coverage-on-tandem-diabetes-care-with-equal-weight-rating-announces-price-target-of-45

Morgan Stanley analyst Patrick Wood initiates coverage on Tandem Diabetes Care (NASDAQ:TNDM) with a Equal-Weight rating and ...

Core News & Articles

Tandem Diabetes Care, Inc. (NASDAQ:TNDM) today announced the planned release of version 2.8.2 of its Apple iOS t:connect mobile...

 tandem-diabetes-care-update-on-march-recall-of-tconnect-mobile-app-for-ios-devices-says-under-delivery-of-insulin-because-of-pump-shutdown-can-be-life-threatening-condition

This battery depletion can result in the pump shutting down sooner than expected, which some customers have continued to experi...

 canaccord-genuity-initiates-coverage-on-tandem-diabetes-care-with-buy-rating-announces-price-target-of-57

Canaccord Genuity analyst William Plovanic initiates coverage on Tandem Diabetes Care (NASDAQ:TNDM) with a Buy rating and an...

 barclays-maintains-overweight-on-tandem-diabetes-care-raises-price-target-to-58

Barclays analyst Matt Miksic maintains Tandem Diabetes Care (NASDAQ:TNDM) with a Overweight and raises the price target from...

 wells-fargo-maintains-overweight-on-tandem-diabetes-care-raises-price-target-to-55

Wells Fargo analyst Larry Biegelsen maintains Tandem Diabetes Care (NASDAQ:TNDM) with a Overweight and raises the price targ...

 baird-maintains-neutral-on-tandem-diabetes-care-raises-price-target-to-39

Baird analyst Jeff Johnson maintains Tandem Diabetes Care (NASDAQ:TNDM) with a Neutral and raises the price target from $36 ...

 piper-sandler-reiterates-overweight-on-tandem-diabetes-care-raises-price-target-to-55

Piper Sandler analyst Matt O'Brien reiterates Tandem Diabetes Care (NASDAQ:TNDM) with a Overweight and raises the price ...

 tandem-diabetes-care-q2-2024-gaap-eps-047-beats-053-estimate-sales-221910m-beat-204902m-estimate

Tandem Diabetes Care (NASDAQ:TNDM) reported quarterly losses of $(0.47) per share which beat the analyst consensus estimate of ...

Core News & Articles

First Automated Insulin Delivery System In Canada To Feature This Integration, Offering Users More Choice In Diabetes Managemen...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION